oru.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Clinicopathological significance of BTF3 expression in colorectal cancer
Dept Oncolgy, Henan Province Peoples Hospital, Zhengzhou University, Zhengzhou, Peoples R China.; Fac Hlth Sci, Div Oncol, Dept Clin & Experimental Medicine, Linköping University, Linköping, Sweden.
Fac Health Science, Div Oncology, Dept Clin & Experimental Med, Linköping University, Linköping, Sweden..
Dept Stomatol, Hosp 1, Hebei Medical University, Shijiazhuang, Peoples R China.
Dept Surg, Vrinnevi Hospital, Linköping University, Norrköping, Sweden.
Show others and affiliations
2013 (English)In: Tumor Biology, ISSN 1010-4283, E-ISSN 1423-0380, Vol. 34, no 4, p. 2141-2146Article in journal (Refereed) Published
Abstract [en]

Basic transcription factor 3 (BTF3) is a general RNA polymerase II transcription factor and is also involved in apoptosis regulation. Increasing evidence shows that BTF3 is aberrantly expressed in several kinds of malignancies, but there is no study to analyze BTF3 expression in colorectal cancer (CRC) patients. Applying immunohistochemistry, we detected BTF3 in CRCs (n = 156), the corresponding distant (n = 42), adjacent normal mucosa (n = 96), lymph node metastases (n = 35), and analyzed its relationships with clinicopathological and biological variables. Our results showed that BTF3 staining significantly increased from distant or adjacent normal mucosa to primary CRCs (p < 0.0001) or metastases (p = 0.002 and p < 0.0001). BTF3 was higher in distal cancers than in proximal cancers (57 % vs. 39 %, p = 0.041). It also showed stronger staining in primary CRCs stage I and II than that in stage III and IV (64 % vs. 35 %, p = 0.0004), or metastases (64 % vs. 29 %, p = 0.004). Cancers with better differentiation had a higher expression than those with worse differentiation (56 % vs. 37 %, p = 0.031). There were positive correlations of BTF3 expression with nuclear factor kappa B (NF-kappa B), RAD50, MRE11, NBS1, and AEG-1 (p < 0.05). In conclusion, BTF3 overexpression may be an early event in CRC development and could be useful biomarker for the early stage of CRCs. BTF3 has positive correlations with NF-kappa B, RAD50, MRE11, NBS1 and AEG-1, and might influence complex signal pathways in CRC.

Place, publisher, year, edition, pages
Springer Netherlands, 2013. Vol. 34, no 4, p. 2141-2146
Keywords [en]
Basic transcription factor 3, Biomarker, Colorectal cancer, Immunohistochemistry
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:oru:diva-54795DOI: 10.1007/s13277-013-0745-8ISI: 000321912500018PubMedID: 23532689Scopus ID: 2-s2.0-84881474571OAI: oai:DiVA.org:oru-54795DiVA, id: diva2:1066462
Funder
Swedish Cancer SocietySwedish Research Council
Note

Funding agency:

Health Research Council in the southeast of Sweden 

Available from: 2017-01-18 Created: 2017-01-18 Last updated: 2018-05-27Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records BETA

Zhang, Hong

Search in DiVA

By author/editor
Zhang, Hong
By organisation
School of Medicine, Örebro University, Sweden
In the same journal
Tumor Biology
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 14 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf